Cardiotoxicity in Non-metastatic Lung Cancer Patients Treated with Chemoradiation Therapy: A Prospective Longitudinal Cohort

Brief description of study

We propose a prospective longitudinal cohort of radiation therapy cardiotoxicity in in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiation. We will enroll patients prior to start of chemoradiation and follow them with echocardiogram, PET/CT stress test, blood draw, and symptoms/activity surveys for 2 years to determine if radiation therapy results in early, sub-clinical cardiovascular dysfunction, to understand how cardiac dose-volume parameters influence these abnormalities, and to develop multi-marker strategies in risk prediction.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Lung Cancer
Age: - 99 Years
Gender: All

Updated on 13 Mar 2024. Study ID: 834810

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).